oral semaglutide vs metformin Will be a game-changer in the management of type 2 diabetes in primary care? Emerging research suggests that GLP-1

Risks that remain real even if the drug does not transfer Drug transfer into milk is only one piece of the puzzle

Interventions Participants consumed one sachet of either i) L-Carnitine-combination (1500 mg given as 2200 mg Carnipure tartrate (Lonza, Switzerland), 2000 mg L-leucine, 3000 mg creatine monohydrate, and 0.01 mg (400 IU) of vitamin-D3), ii) L-Carnitine (1500 mg given as 2200 mg Carnipure tartrate (Lonza, Switzerland)), or iii) appearance- and taste-matched placebo each day, in the morning with breakfast

In the UK, NICE guidance (NG28) recommends considering GLP-1 receptor agonists for patients with type 2 diabetes according to specific criteria, typically when treatment with metformin and other oral medications has not achieved adequate glycaemic control

Six severe and four moderate cases of GSSD have been reported in China